drug resistance

You have access
Urokinase-type Plasminogen Activator Is a Therapeutic Target for Overcoming Sorafenib Resistance in Hepatoma Cells
MAMI OSAWA, YASUNOBU MATSUDA, YOSHIAKI KINOSHITA and TOSHIFUMI WAKAI

Anticancer Research February 2021, 41 (2) 645-660; DOI: https://doi.org/10.21873/anticanres.14816
You have access
Inhibition of Bruton's Tyrosine Kinase Suppresses Cancer Stemness and Promotes Carboplatin-induced Cytotoxicity Against Bladder Cancer Cells
YUEH PAN, YA-HSU CHIU, SHAO-CHIH CHIU, DER-YANG CHO, LIANG-MING LEE, YU-CHING WEN, JACQUELINE WHANG-PENG, CHI-HAO HSIAO and PING-HSIAO SHIH

Anticancer Research November 2020, 40 (11) 6093-6099; DOI: https://doi.org/10.21873/anticanres.14630
You have access
Protein Profiling of Extracellular Vesicles Associated With Cisplatin Resistance in Lung Cancer
HELIER BALBINOTTI, NATHAN A. CADORE, CRISTINE S. DUTRA, EDILEUZA D. DA SILVA, HENRIQUE B. FERREIRA, ARNALDO ZAHA and KARINA M. MONTEIRO

Anticancer Research October 2020, 40 (10) 5509-5516; DOI: https://doi.org/10.21873/anticanres.14563
You have access
Cell Cycle Dysregulation Is Associated With 5-Fluorouracil Resistance in Gastric Cancer Cells
DA SOM KIM, KYOUNGMI MIN and SUK KYEONG LEE

Anticancer Research June 2020, 40 (6) 3247-3254; DOI: https://doi.org/10.21873/anticanres.14306
You have access
Effect of Small-molecule Tyrosine Kinase Inhibitors on PDGF-AA/BB and PDGFRα/β Expression in SCC According to HPV16 Status
LENA HUBER, RICHARD BIRK, NICOLE ROTTER, CHRISTOPH ADERHOLD, ANNE LAMMERT, FREDERIC JUNGBAUER and BENEDIKT KRAMER

Anticancer Research February 2020, 40 (2) 825-835; DOI: https://doi.org/10.21873/anticanres.14014
You have access
Association of ABC Transporter With Resistance to FK866, a NAMPT Inhibitor, in Human Colorectal Cancer Cells
YOKO OGINO, AKIRA SATO, YOHEI KAWANO, TAKAO AOYAMA, FUMIAKI UCHIUMI and SEI-ICHI TANUMA

Anticancer Research December 2019, 39 (12) 6457-6462; DOI: https://doi.org/10.21873/anticanres.13859
You have access
Apatinib Reverses Paclitaxel-resistant Lung Cancer Cells (A549) Through Blocking the Function of ABCB1 Transporter
QUNCHENG ZHANG, YONGAN SONG, XIANGSONG CHENG, ZHIWEI XU, OLAJUYIN AYOBAMI MATTHEW, JIA WANG, ZHIFU SUN and XIAOJU ZHANG

Anticancer Research October 2019, 39 (10) 5461-5471; DOI: https://doi.org/10.21873/anticanres.13739
You have access
Combination Treatment With Sorafenib and Everolimus Regresses a Doxorubicin-resistant Osteosarcoma in a PDOX Mouse Model
TAKASHI HIGUCHI, NORIHIKO SUGISAWA, KENTARO MIYAKE, HIROMICHI OSHIRO, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, ZOEY KLINE, PAIGE BELT, SANT P. CHAWLA, MICHAEL BOUVET, SHREE RAM SINGH, HIROYUKI TSUCHIYA and ROBERT M. HOFFMAN

Anticancer Research September 2019, 39 (9) 4781-4786; DOI: https://doi.org/10.21873/anticanres.13662
You have access
Anti-parasitic Drug Ivermectin Exhibits Potent Anticancer Activity Against Gemcitabine-resistant Cholangiocarcinoma In Vitro
KITTI INTUYOD, CHARIYA HAHNVAJANAWONG, PORNTIP PINLAOR and SOMCHAI PINLAOR

Anticancer Research September 2019, 39 (9) 4837-4843; DOI: https://doi.org/10.21873/anticanres.13669
You have access
Co-treatment With HIV Protease Inhibitor Nelfinavir Greatly Increases Late-phase Apoptosis of Drug-resistant KBV20C Cancer Cells Independently of P-Glycoprotein Inhibition
JI YEONG KIM, YOO JUNG PARK, BYUNG-MU LEE and SUNGPIL YOON

Anticancer Research July 2019, 39 (7) 3757-3765; DOI: https://doi.org/10.21873/anticanres.13524

Main menu

User menu

Search

drug resistance

Pages